Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach.

Saved in:
Bibliographic Details
Title: Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach.
Authors: Tosca EM; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy., Gauderat G; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France., Fouliard S; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France., Burbridge M; Center for Therapeutic Innovation in Oncology, Servier, Suresnes, France., Chenel M; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France., Magni P; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy.
Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Nov; Vol. 10 (11), pp. 1396-1411. Date of Electronic Publication: 2021 Oct 28.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34708556
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tosca+EM%22">Tosca EM</searchLink>; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Gauderat+G%22">Gauderat G</searchLink>; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Fouliard+S%22">Fouliard S</searchLink>; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Burbridge+M%22">Burbridge M</searchLink>; Center for Therapeutic Innovation in Oncology, Servier, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Chenel+M%22">Chenel M</searchLink>; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France.<br /><searchLink fieldCode="AU" term="%22Magni+P%22">Magni P</searchLink>; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101580011%22">CPT: pharmacometrics & systems pharmacology</searchLink> [CPT Pharmacometrics Syst Pharmacol] 2021 Nov; Vol. 10 (11), pp. 1396-1411. <i>Date of Electronic Publication: </i>2021 Oct 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101580011 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2163-8306 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221638306%22">21638306 </searchLink><i>NLM ISO Abbreviation: </i>CPT Pharmacometrics Syst Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34708556
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/psp4.12710
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1396
    Titles:
      – TitleFull: Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tosca EM
      – PersonEntity:
          Name:
            NameFull: Gauderat G
      – PersonEntity:
          Name:
            NameFull: Fouliard S
      – PersonEntity:
          Name:
            NameFull: Burbridge M
      – PersonEntity:
          Name:
            NameFull: Chenel M
      – PersonEntity:
          Name:
            NameFull: Magni P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2021 Nov
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2163-8306
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: CPT: pharmacometrics & systems pharmacology
              Type: main
ResultId 1